These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29704771)

  • 1. New approach based on immunochemical techniques for monitoring of selective estrogen receptor modulators (SERMs) in human urine.
    Salvador JP; Vila-Roca E; Monfort N; Ventura R; Marco MP
    J Pharm Biomed Anal; 2018 Jul; 156():147-152. PubMed ID: 29704771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mass spectrometric approach for the study of the metabolism of clomiphene, tamoxifen and toremifene by liquid chromatography time-of-flight spectroscopy.
    Mazzarino M; Fiacco I; de la Torre X; Botrè F
    Eur J Mass Spectrom (Chichester); 2008; 14(3):171-80. PubMed ID: 18708697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry.
    Görgens C; Guddat S; Thomas A; Wachsmuth P; Orlovius AK; Sigmund G; Thevis M; Schänzer W
    J Pharm Biomed Anal; 2016 Nov; 131():482-496. PubMed ID: 27693991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS/(MS) following in vitro and excretion studies.
    Mazzarino M; Biava M; de la Torre X; Fiacco I; Botrè F
    Anal Bioanal Chem; 2013 Jun; 405(16):5467-87. PubMed ID: 23604525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro phase I metabolism of selective estrogen receptor modulators in horse using ultra-high performance liquid chromatography-high resolution mass spectrometry.
    Kwok KY; Chan GHM; Kwok WH; Wong JKY; Wan TSM
    Drug Test Anal; 2017 Sep; 9(9):1349-1362. PubMed ID: 28054434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric characterization of urinary toremifene metabolites for doping control analyses.
    Gómez C; Pozo OJ; Diaz R; Sancho JV; Vilaroca E; Salvador JP; Marco MP; Hernandez F; Segura J; Ventura R
    J Chromatogr A; 2011 Jul; 1218(29):4727-37. PubMed ID: 21683367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for anabolic steroids in sports: analytical strategy based on the detection of phase I and phase II intact urinary metabolites by liquid chromatography tandem mass spectrometry.
    Balcells G; Pozo OJ; Esquivel A; Kotronoulas A; Joglar J; Segura J; Ventura R
    J Chromatogr A; 2015 Apr; 1389():65-75. PubMed ID: 25746760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric characterization of toremifene metabolites in human urine by liquid chromatography-tandem mass spectrometry with different scan modes.
    Lu J; Wang X; Xu Y; Dong Y; Yang S; Wu Y; Qin Y; Wu M
    Analyst; 2011 Feb; 136(3):467-72. PubMed ID: 21113546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of tamoxifen using LC-MS/MS.
    Tchu SM; Lynch KL; Wu AH
    Methods Mol Biol; 2012; 902():211-22. PubMed ID: 22767121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput liquid chromatography tandem mass spectrometry assay as initial testing procedure for analysis of total urinary fraction.
    Sobolevsky T; Ahrens B
    Drug Test Anal; 2021 Feb; 13(2):283-298. PubMed ID: 32852861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative metabolic study between two selective estrogen receptor modulators, toremifene and tamoxifen, in human liver microsomes.
    Watanabe M; Watanabe N; Maruyama S; Kawashiro T
    Drug Metab Pharmacokinet; 2015 Oct; 30(5):325-33. PubMed ID: 26423799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of tamoxifen urinary metabolites in rat by ultra-high-performance liquid chromatography time-of-flight mass spectrometry.
    Domínguez-Romero JC; García-Reyes JF; Beneito-Cambra M; Martínez-Romero R; Martinez-Lara E; Del Moral-Leal ML; Molina-Díaz A
    Biomed Chromatogr; 2015 Aug; 29(8):1220-8. PubMed ID: 25611330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Process development for the total synthesis of the novel drug metabolite Carboxy toremifene as a standard reference material along with characterization and purity assessment for the Antidoping quality Control Purposes.
    Kumar GJ; Pawar SD; Pawar SR; Khatib AM; Saini A; Das P; Sethi KK; Radhakrishnanand P; Murty US; Sahu PL; Dubey S; Sahu K; Upadhyay A; Kori RK; Kumar P
    Drug Test Anal; 2022 Nov; 14(11-12):2002-2006. PubMed ID: 36229870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: endogenous steroids urinary profile after multiple oral doses.
    Mazzarino M; Braganò MC; de la Torre X; Molaioni F; Botrè F
    Steroids; 2011 Nov; 76(12):1400-6. PubMed ID: 21745489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-line formation, separation, and estrogen receptor affinity screening of cytochrome P450-derived metabolites of selective estrogen receptor modulators.
    van Liempd SM; Kool J; Niessen WM; van Elswijk DE; Irth H; Vermeulen NP
    Drug Metab Dispos; 2006 Sep; 34(9):1640-9. PubMed ID: 16790557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-targeted acquisition strategy for screening doping compounds based on GC-EI-hybrid quadrupole-Orbitrap mass spectrometry: A focus on exogenous anabolic steroids.
    de Albuquerque Cavalcanti G; Rodrigues LM; Dos Santos L; Zheng X; Gujar A; Cole J; Padilha MC; de Aquino Neto FR
    Drug Test Anal; 2018 Mar; 10(3):507-517. PubMed ID: 28600878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural elucidation of new urinary tamoxifen metabolites by liquid chromatography quadrupole time-of-flight mass spectrometry.
    Lu J; He C; He G; Wang X; Xu Y; Wu Y; Dong Y; Ouyang G
    J Mass Spectrom; 2014 Jul; 49(7):570-8. PubMed ID: 25044841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric characterization of tamoxifene metabolites in human urine utilizing different scan parameters on liquid chromatography/tandem mass spectrometry.
    Mazzarino M; de la Torre X; Di Santo R; Fiacco I; Rosi F; Botrè F
    Rapid Commun Mass Spectrom; 2010 Mar; 24(6):749-60. PubMed ID: 20187079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.